Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Steven M. Greenberg(Harvard University), Susanne J. van Veluw(Massachusetts General Hospital), Reisa A. Sperling(Harvard University), Brian J. Bacskai(Massachusetts General Hospital), Jeremy J. Pruzin(Brigham and Women's Hospital), Mar Hernández‐Guillamón(Vall d'Hebron Institut de Recerca)
Cited by 924
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k